Brief: Ampio Pharmaceuticals Reports Fourth-Quarter Financial Results
29/03/2022 21:11
March 29 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO PHARMACEUTICALS REPORTS FOURTH-QUARTER AND FULL-YEAR
2021
FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
* AMPIO PHARMACEUTICALS INC - CASH AND CASH EQUIVALENTS OF
$34
MILLION EXPECTED TO FUND CURRENT OPERATIONS INTO 2H 2023
Source text for Eikon: ID:nPn1GV0m1a
Further company coverage: AMPE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank